Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 112 publications.

Ripollone JE, Huybrechts KF, Rothman KJ, Ferguson RE, Franklin JM. Evaluating the utility of coarsened exact matching for pharmacoepidemiology using real and simulated claims data. Am J Epidemiol. 2019 Dec 17. doi: 10.1093/aje/kwz268

Vinceti M, Filippini T, Malagoli C, Violi F, Mandrioli J, Consonni D, Rothman KJ, Wise LA. Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water: a long-term follow-up. Environ Res. 2019 Dec;179(Pt A):108742. doi: 10.1016/j.envres.2019.108742

Mazurek M, Teutsch C, Diener H-C, Dubner SJ, Halperin JL, Ma C-S, Rothman KJ, Paquette M, Zint K, Franca L, Lu S, Bartels DB, Huisman MV, Lip GYH, GLORIA-AF Investigators. Safety and effectiveness of dabigatran at 2 years: final outcomes from Phase II of the GLORIA-AF registry program. Am Heart J. 2019 Dec;218:123-7. doi: 10.1016/j.ahj.2019.08.012

Skajaa N, Horvath-Puho E, Adelborg K, Botker HE, Rothman KJ, Sorensen HT. Corrigendum to Lack of seasonality in occurrence of pericarditis, myocarditis, and endocarditis [Annals of Epidemiology 37 (2019) 77–80]. Ann Epidemiol. 2019 Dec;40:42. doi: 10.1016/j.annepidem.2019.07.005

Stanford JB, Willis SK, Hatch EE, Rothman KJ, Wise LA. Fecundability in relation to use of fertility awareness indicators in a North American preconception cohort study. Fertil Steril. 2019 Nov;112(5):892-9. doi: 10.1016/j.fertnstert.2019.06.036

Mortamais M, Pujol J, Martínez-Vilavella G, Fenoll R, Reynes C, Sabatier R, Rivas I, Forns J, Vilor-Tejedor N, Alemany S, Cirach M, Alvarez-Pedrerol M, Nieuwenhuijsen M, Sunyer J. Effects of prenatal exposure to particulate matter air pollution on corpus callosum and behavioral problems in children. Environ Res. 2019 Nov;178:108734. doi: 10.1016/j.envres.2019.108734

Garcia-Albeniz X, Alonso V, Escudero P, Méndez M, Gallego J, Rodríguez JR, Salud A, Fernández-Plana J, Manzano H, Zanui M, Falcó E, Feliu J, Gil M, Fernández-Martos C, Bohn U, Alonso C, Calderero V, Rojo F, Cuatrecasas M, Maurel J. Prospective biomarker study in advanced RAS wild‐type colorectal cancer: POSIBA Trial (GEMCAD 10‐02). Oncologist. 2019 Nov;24(11):e1115-22. doi: 10.1634/theoncologist.2018-0728

Sparrow RT, Khan A, Ferreira-Legere L, Ko DT, Jackevicius CA, Goodman SG, Anderson TJ, Stacey D, Tiszovszky I, Farkouh ME, Tu JV, Udell JA. Effectiveness of interventions aimed at increasing statin-prescribing rates in primary cardiovascular disease prevention: a systematic review of randomized clinical trials. JAMA Cardiol. 2019 Nov 1;4(11):1160-9. doi: 10.1001/jamacardio.2019.3066

Salem L, Malouvier A, Blatchford J, Rivero‐Ferrer E, Deltour N, Jacquot E. Ivabradine drug utilization study in five European countries: a multinational, retrospective, observational study to assess effectiveness of risk‐minimization measures. Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1470-9. doi: 10.1002/pds.4880

Arana A. Estudios descriptivos e híbridos. Presented at the VI Encuentro Nacional de Farmacovigilancia y XVI Encuentro Internacional de Farmacovigilancia de las Américas Meeting; October 29, 2019. Bogota, Colombia.

Arana A, Arias A, Salas M. Bases de datos para estudios farmacoepidemiológicos. Presented at the VI Encuentro Nacional de Farmacovigilancia y XVI Encuentro Internacional de Farmacovigilancia de las Américas Meeting; October 29, 2019. Bogota, Colombia.

Brink M, Schaffer B, Vienneau D, Pieren R, Foraster M, Eze IC, Rudzik F, Thiesse L, Cajochen C, Probst-Hensch N, Rooslie M, Wunderli JM. Self-reported sleep disturbance from road, rail and aircraft noise: exposure-response relationships and effect modifiers in the SiRENE study. Int J Environ Res Public Health. 2019 Oct 29;16(21):4186. doi: 10.3390/ijerph16214186

Arana A, Salas M. Implementacion de las medidas de minimizacion de riesgo. Poster presented at the 19th International Society of Pharmacovigilance Annual Meeting; October 28, 2019. Bogota, Colombia.

Arana A. ENCePP. La red Europea de Centros en Farmacoepidemiología y Farmacovigilancia. Ensayos clínicos poblacionales. Presented at the IDIAP Jordi Gol Conference; October 23, 2019. Barcelona, Spain.

Arana A. Diseños farmacoepidemiológicos avanzados: case-series, case cross-over. Presented at the IDIAP Jordi Gol Conference; October 22, 2019. Barcelona, Spain.

Lip GYH, Diener H-C, Dubner SJ, Halperin JL, Rothman KJ, Ma C-S, Lu S, Paquette M, Riou Franca L, Zint K, Teutsch C, Huisman MV. Treatment persistence of patients with atrial fibrillation on VKA or NOAC: data from GLORIA-AF Phase III 1-year interim analysis. Poster presented at the 2019 ESC Congress; August 2019. Paris, France. [abstract] Eur Heart J. 2019 Oct 21; 40(Supplement 1):ehz745.11. doi: 10.1093/eurheartj/ehz745.1159

Hoffman V, Xue F, Ezzy SM, Yusuf A, Green E, Eisele O, Kurth T, Seeger JD. Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: an observational cohort study. Cephalalgia. 2019 Oct;39(12):1544-59. doi: 10.1177/0333102419856630

Garcia-Albeniz X, Hsu J, Bretthauer M, Hernan MA. Estimating the effect of preventive services with databases of administrative claims: reasons to be concerned. Am J Epidemiol. 2019 Oct;188(10):1764-7. doi: 10.1093/aje/kwz049

Timmer A, de Sordi D, Kappen S, Kohse KP, Schink T, Perez-Gutthann S, Jacquot E, Deltour N, Pladevall M. Validity of hospital ICD-10-GM codes to identify acute liver injury in Germany. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1344-52. doi: 10.1002/pds.4855

Glynn RJ, Lunt M, Rothman KJ, Poole C, Schneeweiss S, Sturmer T. Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1290-8. doi: 10.1002/pds.4846

Gilsenan A, Fortuny J, Cainzos-Achirica M, Cantero OF, Flynn RWV, Garcia-Rodriguez L, Harding A, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Odsbu E, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Cardiovascular safety of prucalopride in patients with chronic constipation: a multinational population-based cohort study. Drug Saf. 2019 Oct;42(10):1179-90. doi: 10.1007/s40264-019-00835-0

Hoffman V, Xue F, Ezzy SM, Yusuf A, Green E, Eisele O, Kurth T, Seeger JD. Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine treated with prophylactic medications: an observational cohort study. Cephalalgia. 2019 Oct;39(12):1544-59. doi: 10.1177/0333102419856630

Abellan A, Sunyer J, Garcia-Esteban R, Basterrechea M, Duarte-Salles T, Ferrero A, Garcia-Aymerich J, Gascon M, Grimalt JO, Lopez-Espinosa MJ, Zabaleta C, Vrijheid M, Casas M. Prenatal exposure to organochlorine compounds and lung function during childhood. Environ Int. 2019 Oct;131:105049. doi: 10.1016/j.envint.2019.105049

Fortuny J, Gilsenan A, Cainzos-Achirica M, Cantero OF, Flynn RWV, Garcia-Rodriguez L, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Study design and cohort comparability in a study of major cardiovascular events in new users of prucalopride versus polyethylene glycol 3350. Drug Saf. 2019 Oct;47(10):1167-77. doi: 10.1007/s40264-019-00836-z

Dickerman BA, Garcia-Albeniz X, Logan RW, Denaxas S, Hernan MA. Avoidable flaws in observational analyses: an application to statins and cancer. Nat Med. 2019 Oct;25(10):1601-6. doi: 10.1038/s41591-019-0597-x

Garcia de Albeniz X, Hernan M, Logan R, Price M, Hsu J. Continuation of annual screening mammograms and breast-cancer mortality in women over 70. Poster presented at the ESMO 2019 Congress; September 27, 2019. Barcelona, Spain.

Margulis AV, Anthony M, Rivero-Ferrer E. Drug safety in pregnancy: review of study approaches requested by regulatory agencies. Curr Epidemiol Rep. 2019 Sep;6(3):380-9. doi: 10.1007/s40471-019-00212-6

Bykov K, He M, Franklin JM, Garry EM, Seeger JD, Patorno E. Glucose-lowering medications and the risk of cancer: A methodological review of studies based on real-world data. Diabetes Obes Metab. 2019 Sep;21(9):2029-38. doi: 10.1111/dom.13766.

Hahn KA, Wesselink AK, Wise LA, Mikkelsen EM, Cueto HT, Tucker KL, Vinceti M, Rothman KJ, Sorensen HT, Hatch EE. Iron consumption is not consistently associated with fecundability among North American and Danish pregnancy planners. J Nutr. 2019 Sep 1;149(9):1585-95. doi: 10.1093/jn/nxz094.

Li W, Zou T, Li L, Deng Y, Sun VT, Zhang Q, Layton B, Setoguchi S. Impacts of the North Atlantic subtropical high on interannual variation of summertime heat stress over the conterminous United States. Clim Dyn. 2019 Sep;53(5-6):3345-59. doi: 10.1007/s00382-019-04708-1

Fernandez-Martos C, Pericay C, Losa F, Garcia-Carbonero R, Layos L, Rodriguez-Salas N, Martin-Richard M, Alonso-Orduna V, Vera R, Gallegeo J, Capdevila J, Salud A, Nogue M, Maurel J, Guash I, Montagut C, Lopez C, Macias I, Jain RK, Garcia-Albeniz X. Effect of aflibercept plus modified FOLFOX6 induction chemotherapy before standard chemoradiotherapy and surgery in patients with high-risk rectal adenocarcinoma: the GEMCAD 1402 randomized clinical trial. JAMA Oncol. 2019 Aug 29;5(11):1566-73. doi: 10.1001/jamaoncol.2019.2294

Bateman B, Huybrechts K, Margulis A, Rothman KJ. Modern pregnancy pharmacoepidemiology: selected analytical considerations in the study of drug safety in pregnancy. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2019. Philadelphia, PA.

Auth D, Gilsenan A, Morrato E, Smith M. Effective risk management: best practices for designing, implementing and evaluating risk minimization programs. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2019. Philadelphia, PA. Previously presented at the 34th Annual ICPE Conference.

Garcia-Albeniz X, Hsu J, Hernan MA. A challenge of real world data: How to assign individuals to a treatment strategy when their data are consistent with several treatment strategies at baseline. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):476. doi: 10.1002/pds.4864

Zhou CK, Dinh J, Danysh HE, Johannes C, Gutierrez L, Schmid R, Arana A, Kaye JA, Pladevall-Vila M, Garcia-Albeniz X, Gangemi K, Yin R, Ruzafa JC, Gilsenan A, Beachler DC. Validity of claims-based algorithms to identify acute kidney injury, acute liver injury, severe complications of urinary tract infections, breast cancer, and bladder cancer among patients with type 2 diabetes: a pilot study. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):317. doi: 10.1002/pds.4864

Gilsenan A, Fortuny J, Cainzos-Achirica M, Cantero OF, Flynn RW, Garcia-Rodriguez L, Harding A, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Odsbu I, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Cardiovascular safety of prucalopride for chronic constipation: a multinational population-based cohort study. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):33. doi: 10.1002/pds.4864

Gilsenan A, Midkiff K, Harris D, McQuay L, Hunter S, Kellier-Steele N, Andrews E. Assessing the incidence of osteosarcoma among teriparatide users via linkage of data from Medicare Part D and multiple state cancer registries in the United States. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):683.

Gutierrez L, Bezemer ID, Dress J, Ehrenstein V, Forstner M, Franzoni C, Lassalle R, Linder M, Droz-Perroteau C, Odsbu I, Overbeek JA, Perez-Gutthann S, Pisa FE, Rascher K, Rasouliyan L, Reinold J, Rothman KJ, Saigi-Morgui N, Schaller M, Smits E, Timmer A, Toft G, von Gersdorff G, Fortuny J. Challenges in conducting a multinational European study of severe hypersensitivity reactions among recipients of intravenous iron. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):640. doi: 10.1002/pds.4864

Gutierrez L, Booth H, Dedman D, Crellin E, Kaye JA, Franzoni C, Arana A, Schmitt-Egenolf M, Sundstrom A, Bystrom C. Case validation of cutaneous lymphoma to minimize protopathic bias. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):645. doi: 10.1002/pds.4864

Gilsenan AW, Brainsky A, Colilla S. Applying CIRS-BRAT framework in a regulatory setting: updated benefit risk assessment for fibrinogen concentrate in the setting of complex cardiac surgery. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):964. doi: 10.1002/pds.4864

Gilsenan AW, Ritchey ME, Hauber B, Andrews EB. Considerations when applying a structured benefit-risk assessment to drug delivery combination products. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):952. doi: 10.1002/pds.4864

Pajouheshnia R, Gardarsdottir H, Platt R, Toh D, Klungel O. Analysis of data from distributed pharmacoepidemiologic networks. Presented at the 35th International Conference of Pharmacoepidemiology & Therapeutic Risk Management; August 21, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):414. doi: 10.1002/pds.4864Pharmacoepidemiol Drug Saf. 2019;28(S2):5–wileyonlinelibrary.com/journal/pds5586

Pajouheshnia R, Schuster N, Groenwold R, Peelen L. Methods to account for time-varying medication use when developing a model for patient prognosis. Presented at the 35th International Conference of Pharmacoepidemiology & Therapeutic Risk Management; August 21, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):232.

Rebordosa C, Houben E, Laugesen K, Asmar J, Montonen JT, Aguado J, Overbeek J, Ehrenstein V, Wallace L, Gilsenan A. Utilization of olodaterol and indacaterol in Europe. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):1128. doi: 10.1002/pds.4864

Saltus CW, Gatz J, Ritchey ME, Ichikawa LE, Armstrong MA, Alabster AL, Merchant M, Lynen R, Asiimwe A, Shi JM, Getahun DT, Xie F, Chiu VY, Anthony MS. Study of the association of uterine perforation and IUD expulsion with breastfeeding and postpartum timing at IUD insertion (APEX IUD) - study size estimation to actuality. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):748. doi: 10.1002/pds.4864

Fortuny J, Gilsenan AW, Cainzos-Achirica M, Cantero OF, Flynn RW, Garcia-Rodriguez L, Kollhorst B, Karlsson P, Linner L, MacDonald TM, Plana E, Ruigomez A, Schink T, Ziemiecki R, Andrews EB. Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort in a multinational study: study design and comparability of cohorts. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):627. doi: 10.1002/pds.4864

Jacquot E, Olivier V, Percheron C, Mazens F, Deltour N, Perez-Gutthann S. Agomelatine post-authorization safety studies program: comprehensive results. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):500. doi: 10.1002/pds.4864

Saigi N, Rebordosa C, Bui C, Aguado J, Plana E, Nuevo J, Daoud SZ, Lei A, Perez-Gutthann S, Rivero-Ferrer E. A validation exercise: identifying hospitalizations for heart failure among patients with COPD in the CPRD. Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):334. doi: 10.1002/pds.4864

Layton JB, Li W, Wang L, Yuan J, Gilman JP, Horton DB, Setoguchi S. Heatwaves and heat-sensitizing medications in vulnerable older adults. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):870. doi: 10.1002/pds.4864

Layton JB, Butler AM, Brookhart MA, Panozzo CA. Variation in rotavirus vaccination coding in US State Medicaid data. Presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):852. doi: 10.1002/pds.4864